Key result
Defect closure of a large secundum atrial septal defect masquerading as methamphetamine-induced pulmonary artery hypertension resulted in the patient being asymptomatic at 1 year.
Case Report (n=1)
Highlights the importance of thorough physical examination to avoid diagnostic anchoring bias when evaluating pulmonary artery hypertension in patients with methamphetamine abuse.
Methamphetamine abuse is an increasingly prevalent cause of pulmonary artery hypertension in the United States. Conversely, an atrial septal defect rarely presents late as pulmonary artery hypertension. We present the case of a 44-year-old methamphetamine abuser who had a 3-month history of worsening fatigue and near-syncope. She had elevated cardiac enzyme levels and right-sided heart strain. Angiographic findings suggested methamphetamine-induced pulmonary artery hypertension; however, we later heard S 2 irregularities that raised suspicion of an atrial septal defect. Ultimately, the diagnosis was pulmonary artery hypertension and a large secundum atrial septal defect with left-to-right flow. One year after defect closure, the patient was asymptomatic. In addition to discussing this unexpected case of a secundum atrial septal defect masquerading as methamphetamine-induced pulmonary artery hypertension, we briefly review the natural history of atrial septal defects and emphasize the importance of thorough examination in avoiding diagnostic anchoring bias.
No takes yet. Share an insight, caveat, or question.
Parikh et al. (2018) conducted a case report in Pulmonary artery hypertension and atrial septal defect (n=1). Defect closure was evaluated on Symptom resolution. Defect closure of a large secundum atrial septal defect masquerading as methamphetamine-induced pulmonary artery hypertension resulted in the patient being asymptomatic at 1 year.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: